Fulcrum Therapeutics, Inc. (FULC)

NASDAQ: FULC · Real-Time Price · USD

10.86

-0.01 (-0.09%)

At close: Feb 12, 2026, 4:00 PM EST

10.71

-0.15 (-1.38%)

Pre-market: Feb 13, 2026, 7:06 AM EST

Fulcrum Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	716	254	417	379	717	319
Market Cap Growth	227.96%	-39.25%	10.13%	-47.15%	124.42%	-14.89%
Enterprise Value	523	5	172	171	477	192
Last Close Price	10.86	4.70	6.75	7.28	17.69	11.71
PS Ratio	-	3.17	148.77	59.75	37.41	36.21
PB Ratio	2.96	1.04	1.77	1.91	3.39	3.36
P/TBV Ratio	3.61	1.04	1.77	1.91	3.39	3.36
EV/Sales Ratio	-	0.07	61.21	26.99	24.87	21.82
Debt / Equity Ratio	0.04	0.04	0.05	0.07	-	0
Net Debt / Equity Ratio	-0.98	-0.96	-0.96	-0.95	-1.03	-1.19
Net Debt / EBITDA Ratio	2.42	12.74	2.08	1.73	2.78	1.63
Net Debt / FCF Ratio	3.21	93.11	2.46	1.91	2.72	2.05
Asset Turnover	-	0.31	0.01	0.03	0.11	0.07
Quick Ratio	17.33	22.13	17.44	12.20	11.58	4.33
Current Ratio	17.70	22.63	17.71	12.41	11.77	4.47
Return on Equity (ROE)	-31.21%	-4.07%	-44.84%	-53.53%	-52.72%	-77.68%
Return on Assets (ROA)	-20.63%	-4.78%	-28.56%	-30.36%	-27.79%	-37.30%
Return on Capital Employed (ROCE)	-40.10%	-7.90%	-45.40%	-53.40%	-37.60%	-69.60%
Earnings Yield	-9.93%	-3.84%	-23.33%	-28.99%	-11.28%	-22.17%
FCF Yield	-8.43%	-0.98%	-21.92%	-26.13%	-11.19%	-17.21%
Buyback Yield / Dilution	-0.19%	-1.10%	-36.27%	-27.23%	-39.47%	-129.53%

Updated Oct 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q